- Home
- IIF vs RPID Comparison
IIF vs RPID Comparison
Compare IIF & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IIF | RPID |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.5M | 204.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IIF | RPID |
|---|---|---|
| Price | $23.50 | $4.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 41.9K | ★ 166.0K |
| Earning Date | 01-01-0001 | 04-02-2026 |
| Dividend Yield | ★ 13.94% | N/A |
| EPS Growth | N/A | ★ 11.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $28,051,000.00 |
| Revenue This Year | N/A | $19.91 |
| Revenue Next Year | N/A | $21.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.57 |
| 52 Week Low | $22.20 | $1.86 |
| 52 Week High | $28.37 | $4.94 |
Technical Indicators
Market Signals| Indicator | IIF | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 56.80 |
| Support Level | $23.12 | $3.03 |
| Resistance Level | $27.70 | $4.46 |
| Average True Range (ATR) | 0.33 | 0.33 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 19.71 | 77.05 |
Price Performance
Historical ComparisonAbout IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.